UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, ~~2013~~2014

TRANSITION REPORT PURSUANT TO SECTION 13 OR

15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 333-127170

ANALYTICA BIO-ENERGY ~~INC~~CORP.

(Exact name of small business issuer as specified in its charter)

Delaware n/a 98-0476582

---------------- ---------------------------- ----------------

(State or other (Primary Standard Industrial (I.R.S. Employer

jurisdiction of Classification Code Number) Identification

incorporation Code Number)

or organization)

1896 Stoneybrook Court,

Mississauga, ON L5L 3W2

905-824-6200

(Registrant’s telephone number, including area code)

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the last 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes X No

The number of shares of Common Stock, no par value, outstanding on was 2129,180,294 shares as of September 30, ~~2013~~2014.

Transitional Small Business Disclosure Format (check one): Yes X No

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements.

Our financial statements included in this Form 10-Q are as follows:
	Consolidated Balance Sheets as of September 30, 2013 (unaudited) and July 31, 2013 (unaudited);
	Consolidated Balance Sheets as of September 30, 2014 (unaudited) and December 31, 2013 (unaudited);
	Consolidated Statements of Operations for the two months ended September 30, 2013 and 2012(unaudited) and for the period ended September 30, 2013 and September 30, 2012(unaudited)
	Consolidated Interim Statements of Operations for the nine months ended September 30, 2014 and 2013(unaudited)
	Consolidated Statement of Stockholders’ Equity from July 31, 2008 to September 30, 2013 (unaudited);
	Consolidated Statement of Stockholders’ Equity from July 31, 2008 to September 30, 2014 (unaudited);
	Consolidated Statements of Cash Flows for the period ended September 30, 2013 and 2012 (unaudited);
	Consolidated Interim Statements of Cash Flows for the nine months ended September 30, 2014 and September 30, 2013 (unaudited);
	Notes to Consolidated Financial Statements;
	Notes to Interim Consolidated Financial Statements;

ANALYTICA BIO-ENERGY INC.
ANALYTICA BIO-ENERGY CORP.
Consolidated Balance Sheets (Unaudited)
(all in USD)		(Consolidated)	(Consolidated)
				30-Sep-13	31-Jul-13
		30-Sep-14	31-Dec-13
Current Assets
	Cash and Cash Equivalents	$ 13,741	$ 40,748	~~$ 88,480~~	~~$ 28,826~~
	Accounts receivable	171,248	59,261	~~21,188~~	-
	Prepaid expenses and sundry			93,938	-
	Inventories	12,492
Total Current Assets				$ 203,606	$ 28,826
	Sundry assets	51,414	1,331
	Property and Equipment - Net of Accumulated Depreciation			51,986	0
Total Current Assets		$ 248,895	$ 101,340
Other Assets
FIXED ASSETS(NET OF ACCUMULATED DEPRECIATION)		47,938	-
	Goodwill			5,773,233
Other Assets
Total Assets				$ 6,028,825	$ 28,826
	Intangible assets - other	205	195
Current Liabilities
	Deferred tax assets	46,847	47,467
	Accounts Payable and Accrued Liabilities			$ 308,647	$ 292,500
	Patents	56,000	56,000
	Short-Term Loans			382,823
Total Assets		$ 399,885	$ 205,002
Total Current Liabilities				$691,470	$292,500
Current Liabilities
Other Liabilities
	Accounts Payable and Accrued Liabilities	$ 110,649	$ 55,466
	Long Term Notes Payable			$0	$0
	Witholding taxes payable	-	1,892
	Shareholder Advances			0	0
	Unearned revenue	377,884
Total Liabilities				$691,470	$292,500
	Advances by shareholders	316,754	543,447
Shareholders' Equity
	Due to related parties	-	16,653
	Common Stock, $0.001 par value 50,000,000 shares authorized
Total Current Liabilities		$805,287	$617,458
	- 21,180,294 shares issued and outstanding September 30, 2013 and			$ 21,180	$ 21,180
Shareholders' Equity
	July 31, 2013
	Common Stock, $0.001 par value 50,000,000 shares authorized
	Common shares issuable(6,000,000)			6,000	-
	- 29,180,294 shares issued and outstanding September 30, 2014 and December 31, 2013	$ 29,180	$ 21,180
	Additional Paid In Capital			9,744,366	2,270,357
	Common shares issuable(December 31, 2013 - 8,000,000)	-	8,000
	Retained Earnings			(4,578,764)	(2,699,784)
	Additional Paid In Capital	4,119,067	4,119,067
	Accumulated Comprehensive Income			144,573	144,573
	Retained Earnings(Deficit)	(4,683,113)	(4,690,167)
Total Shareholders' Equity				$ 5,337,355	$ (263,674)
	Accumulated Comprehensive Income	129,464	129,464
Total Liabilities and Shareholders' Equity				$ 6,028,825	$ 28,826
Total Shareholders' Equity		$ (405,402)	$ (412,456)
Total Liabilities and Shareholders' Equity		$ 399,885	$ 205,002

The accompanying notes are an integral part of these financial statements.

ANALYTICA BIO-ENERGY INC.
ANALYTICA BIO-ENERGY CORP.
Consolidated Statement of Operations (unaudited)
Statement of Operations (unaudited)
(all in USD)	FOR THE NINE MONTHS
		Period Ended September 30,
	ENDED
		2013	2012
	SEPTEMBER 30,
Net Revenues:
	2014	2013
Sales		$34,142	$ -
Net Revenues:
Total Net Revenues		$34,142	$0
Sales	$75,325	$ 34,142
Cost of Revenues and Operating Expenses:
Total Net Revenues	$75,325	34,142
Cost of Revenues		$17,751	$0
Cost of Revenues and Operating Expenses:
General and Administrative		149,028	15,000
Cost of Sales	42,368	17,751
Exchange Loss		-	-
General and Administrative	25,954	149,028
Total Operating Expenses		$166,779	$15,000
Other items	- 51	-
Operating (Loss) Income from Operations		($132,637)	($15,000)
Total Operating Expenses	$68,271	$166,779
(Loss) Income Before Income Taxes		($132,637)	($15,000)
Operating (Loss) Income from Operations	$7,054	($132,637)
(Benefit From) Provision for Income Taxes		-	-
Reversal of prior years' accounts payable	-	-
Net (Loss) Income		($132,637)	($15,000)
(Loss) Income Before Income Taxes	7,054	($132,637)
Comprehensive Income
(Benefit From) Provision for Income Taxes	0	0
Foreign Currency Translation Income		-	-
Net (Loss) Income	$7,054	($132,637)
Total Comprehensive Income (Loss)		($132,637)	($15,000)
Comprehensive Income
Net (Loss) Income Per Share - Basic and Diluted		$ (0.01)	$ (0.00)
Foreign Currency Translation Income	0	0
Weighted Average Shares Outstanding - Basic and Diluted		21,180,294	21,180,294
Total Comprehensive Income (Loss)	$7,054	($132,637)
Net (Loss) Income Per Share - Basic and Diluted	$ 0.00	$ (0.01)
Weighted Average Shares Outstanding - Basic and Diluted	29,180,294	21,180,294

The accompanying notes are an integral part of these financial statements.

ANALYTICA BIO-ENERGY INC.
ANALYTICA BIO-ENERGY CORP.
Consolidated Statement of Operations (unaudited)
Consolidated Statement of Stockholders' Equity (unaudited)
(all in USD)
						Two Months Ended September 30,
	Common Stock
						2013	2012
	Shares		Amount	Additional Paid in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Net Revenues:
Balance, July 31, 2008	21,180,294		$ 21,180	$ 1,774,313	$ (1,397,681)	$ 144,448	$ 542,260
Sales						$7,586	$ -
Capital contribution during the year				245,053			245,053
Total Net Revenues						$7,586	-
Net loss for the year					(319,826)		(319,826)
Cost of Revenues and Operating Expenses:
Currency translation adjustment						125	125
Cost of Revenues						$3,945	-
Balance, July 31, 2009		21,180,294	21,180	2,019,366	(1,717,507)	144,573	467,612
General and Administrative						44,784	15,000
Capital contribution during the year				250,991			250,991
Exchange Loss						-	-
Net loss for the year					(741,103)		(741,103)
Total Operating Expenses						$48,729	$15,000
Balance, July 31, 2010		21,180,294	21,180	2,270,357	(2,458,610)	144,573	(22,500)
Operating (Loss) Income from Operations						($41,143)	($15,000)
Capital contribution during the year							0
(Loss) Income Before Income Taxes						($41,143)	($15,000)
Net loss for the year					(90,000)		(90,000)
(Benefit From) Provision for Income Taxes						0	0
Balance, July 31, 2011		21,180,294	21,180	2,270,357	(2,548,610)	144,573	(112,500)
Net (Loss) Income						($41,143)	($15,000)
Net loss - July 31, 2012					(90,000)		(90,000)
Comprehensive Income
Balance, July 31, 2012		21,180,294	21,180	2,270,357	-2,638,610	144,573	-202,500
Foreign Currency Translation Income						0	0
Net loss - July 31, 2013					(90,000)		(90,000)
Total Comprehensive Income (Loss)						($41,143)	($15,000)
Balance, July 31, 2013		21,180,294	21,180	2,270,357	-2,728,610	144,573	-292,500
Net (Loss) Income Per Share - Basic and Diluted						$ (0.00)	$ (0.00)
Acquisition of company				1,637,139	(1,728,706)		(91,567)
Weighted Average Shares Outstanding - Basic and Diluted						21,180,294	21,180,294
Adjustment to acquisition				211,571	(437,500)	(27,733)	(253,662)
Other comprehensive income						12,624	12,624
Net income- December 31, 2013					204,649		204,649
Balance - December 31, 2013	21,180,294		$ 21,180	$ 4,119,067	$ (4,690,167)	$ 129,464	($420,456)
Issuance of common shares	8,000,000		8,000	-	-	-	8,000
Net income - September 30, 2014	-		-	-	7,054		7,054
Balance - September 30, 2014	29,180,294		$ 29,180	$ 4,119,067	($4,683,113)	$ 129,464	($405,402)

The accompanying notes are an integral part of these financial statements.

ANALYTICA BIO-ENERGY INC.
ANALYTICA BIO-ENERGY CORP.
Consolidated Statements of Stockholders' Equity (unaudited)
Statement of Cash Flows (unaudited)
(all in USD)
			FOR THE NINE MONTHS
	Common Stock
(all in USD)			ENDED
	Shares	Amount	Additional Paid in Capital	Retained Earnings	Accumulated Other Comprehensive Income	Total
			SEPTEMBER 30,
Balance, July 31, 2008	21,180,294	$ 21,180	$ 1,774,313	$ (1,397,681)	$ 144,448	$ 542,260
			2014	2013
Capital contribution during the year			245,053			245,053
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss for the year				(319,826)		(319,826)
Net Income (Loss)			$ 7,054	$ (132,637)
Currency translation adjustment					125	125
Items not requiring a current outlay of cash
Balance, July 31, 2009	21,180,294	21,180	2,019,366	(1,717,507)	144,573	467,612
Deferred tax expense			620	-
Capital contribution during the year			250,991			250,991
Depreciation			10,602	5,440
Net loss for the year				(712,277)		(712,277)
Changes in Operating Assets and Liabilities
Balance, July 31, 2010	21,180,294	21,180	2,270,357	(2,429,784)	144,573	6,326
Accounts receivable			(111,987)	(21,188)
Capital contribution during the year						0
Inventories			(12,492)	-
Net loss for the year				(90,000)		(90,000)
Sundry			(50,093)	(93,938)
Balance, July 31, 2011	21,180,294	21,180	2,270,357	(2,519,784)	144,573	(83,674)
Accounts Payable & Accrued Liabilities			55,183	16,147
Net loss - July 31, 2012				(90,000)		(90,000)
Withholding taxes			(1,892)	-
Balance, July 31, 2012	21,180,294	21,180	2,270,357	(2,609,784)	144,573	(173,674)
Unearned revenue			377,884	-
Net loss - July 31, 2013				(90,000)		(90,000)
NET CASH FLOWS PROVIDED BY OPERATING ACTIVITIES			274,879	(226,176)
Balance, July 31, 2013	21,180,294	21,180	2,270,357	(2,699,784)	144,573	(263,674)
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of company			7,474,009	(1,746,343)		5,727,666
Acquisition of company - net			-	(96,993)
Net loss - September 30, 2013				(132,637)		(132,637)
Fixed assets			(58,540)	-
Balance - September 30, 2013	21,180,294	$ 21,180	$ 9,744,366	$ (4,578,764)	$ 144,573	$ 5,331,355
NET CASH USED IN INVESTING ACTIVITIES			(58,540)	(96,993)
CASH FLOWS FROM FINANCING ACTIVITIES
Due to related parties			(16,653)	-
Advances by shareholders			(226,693)	382,823
NET CASH FLOWS USED IN FINANCING ACTIVITIES			(243,346)	382,823
NET CHANGE IN CASH AND CASH EQUIVALENTS			(27,007)	59,654
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD			40,748	28,826
CASH AND CASH EQUIVALENTS, END OF PERIOD			$ 13,741	$ 88,480
SUPPLEMENTAL DISCLOSURES
Interest Paid				$ -
Income Taxes Paid				$ -

The accompanying notes are an integral part of these financial statements.

ANALYTICA BIO-ENERGY INC.
Consolidated Statement of Cash Flows (unaudited)
(all in USD)
	Period Ended September 30,
	2013	2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss)	$ (132,637)	$ (15,000)
Items not requiring a current outlay of cash
Depreciation	5,440
Changes in Operating Assets and Liabilities
Accounts receivable	(21,188)
Prepaid expenses and sundry	(93,938)
Accounts Payable & Accrued Liabilities	16,147	15,000
NET CASH FLOWS(USED IN) PROVIDED BY OPERATING ACTIVITIES	(226,176)	-
CASH FLOWS FROM FINANCING ACTIVITES
Short term loans	382,823	-
NET CASH FLOWS FROM FINANCING ACTIVITIES	382,823	-
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of company - net	(96,993)
NET CASH USED IN INVESTING ACTIVITIES	(96,993)
NET CHANGE IN CASH AND CASH EQUIVALENTS	59,654	-
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	28,826	28,826
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 88,480	$ 28,826
SUPPLEMENTAL DISCLOSURES
Interest Paid	$ -	$ -
Income Taxes Paid	$ -	$ -
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Contributed Services by Stockholders	$ 15,000	$ 15,000

ANALYTICA BIO-ENERGY CORP.

The accompanying notes are an integral part of these financial statements.

ANALYTICA BIO-ENERGY INC.

Notes to Interim Consolidated Financial Statements

September 30, ~~2013~~2014

(Unaudited)

ORGANIZATION AND BUSINESS BACKGROUND

Analytica Bio-Energy ~~Inc.~~Corp formerly Uniwell Electronic Corporation, (“~~The~~ Company”) was ~~formed~~incorporated onas ~~January~~a ~~12,~~Sino-American ~~2004,~~joint ~~under~~venture ~~the~~with ~~laws~~a oflimited ~~the~~liability ~~State~~in ~~of Delaware. The Company'~~People’s ~~original~~Republic ~~incorporation~~of ~~was~~China ~~under~~on ~~the~~September ~~name of Nitar Tech~~30, ~~Corp~~2005. OnThe ~~July 24, 2004, the~~ Company ~~acquired~~is ~~all~~located ofin ~~the outstanding shares of Labtech Systems Inc.~~Huizhou, ~~(an~~Guangdong ~~Ontario~~and ~~Canada~~principally ~~Corporation)~~engaged in amanufacturing ~~reverse~~various ~~merger~~printed inflexible ~~exchange~~circuits. The ~~for~~Company ~~approximately~~ceased ~~67%~~operations ofin ~~the~~May ~~outstanding~~2010 ~~stock~~and ofhas ~~the~~been ~~Company.~~looking ~~The~~to ~~Company~~acquire ~~had~~an noactive ~~operating~~viable ~~activities prior to the reverse merger~~business.

In July ~~2009~~2013, the Company ~~signed~~changed anits ~~Agreement~~name ~~for~~to ~~the~~Analytica ~~Exchange~~Bio-Energy ~~of Common Stock with Winscon Electronics Co~~Corp. ~~Ltd. out of China.~~

InThe ~~August~~year ~~2009,~~end of the Company ~~changed~~is ~~its~~December ~~name to Winscon Electronics Co~~31. ~~Ltd.~~

In As ~~July~~reflected ~~2010~~in the accompanying combined financial statements, the Company ~~changed~~has ~~its~~accumulated ~~name~~deficits of $4,683,113 at September 30, 2014. The Company’s owners have funded the losses and cash shortfalls allowing management to ~~Uniwell~~develop ~~Electronic~~sales ~~Corporation~~and contingencies plans. The Company is also arranging for additional funding. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

In July 2013, the Company changed its name to Analytica Bio-Energy Inc.

The Company acquired for 6,000,000 shares of its restricted common stock effective September 30, 2013 all of the outstanding shares of Analytica Bioenergy, Inc., a Taiwanese company. The value placed on the acquisition was $6,000,000.

In July 2013, the Company changed its year-end from July 31 to December 31.

As reflected in the accompanying combined financial statements, the Company has accumulated deficits of $4,578,764 at September 30, 2013. The Company’s owners have funded the losses and cash shortfalls allowing management to develop sales and contingencies plans. The Company is also arranging for additional funding. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Preparation

The accompanying financial statements have been prepared by the Company in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). All intercompany transactions have been removed.

In the opinion of the management, ~~the~~these interim consolidated financial statements reflect all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position of the Company as of September 30, ~~2013~~2014, and the results of operations and cash flows for the ~~period~~nine months ended September 30, ~~2013~~2014. ~~All if any intercompany transactions have been eliminated.~~

Reclassification

Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported losses.

Use of Estimates

In preparing these financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the year reported. Actual results may differ from these estimates. The Company regularly evaluates estimates and assumptions related to obsolete inventory, useful life and recoverability of long lived assets, and goodwill. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Subsequent Events

The Company has evaluated subsequent events through the date that these financial statements were issued, which was November 4, 2013, the date of the Company’s Quarterly Report for the period ended September 30, 2013.

Fair Value of Financial Instruments

The Company adopted the standard “Fair Value Measurements”, codified with ASC 820 and effective January 1, 2008. The provisions of ASC 820 are to be applied prospectively.

ASC 820 clarifies that fair value is an estimate of the exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants (i.e., the exit price at the measurement date). Under ASC 820, fair value measurements are not adjusted for transaction cost. ASC 820 provides for use of a fair value hierarchy that prioritizes inputs to valuation techniques used to measure fair value into three levels:

Level 1:

Unadjusted quoted prices in active markets for identical assets or liabilities

Level 2:

Input other than quoted market prices that are observable, either directly or indirectly, and reasonably available. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the Company.

Level 3:

Unobservable inputs. Unobservable inputs reflect the assumptions that the Company develops based on available information about what market participants would use in valuing the asset or liability.

An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.

fe.

Cash and Cash Equivalents

Cash and cash equivalents include cash on hand, demand deposits with banks and liquid investments with an original maturity of three months or less.

gf.

Comprehensive income

The standard, “Reporting Comprehensive Income”, codified with ASC 220, requires disclosure of all components of comprehensive income and loss on an annual and interim basis. Comprehensive income and loss is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. The comprehensive income arose from the effect of foreign currency translation adjustments.

hg.

Revenue recognition

The Company generates revenues from the sales of printed flexible circuits. Sales are recognized when the following four revenue criteria are met: persuasive evidence of an arrangement exists, delivery has occurred, the selling price is fixed or determinable, and collectability is reasonably assured. Sales are presented net of value added tax (VAT). No return allowance is made as products returns are insignificant based on historical experience.

Income taxes

The Company accounts for income taxes in accordance with the standard, "Accounting for Income Taxes.", codified with ASC 740, requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Group is able to realize their benefits, or that future deductibility is uncertain.

jh.

Foreign currency translation

The Company’s financial information is presented in US dollars. The functional currency of the Company is New Taiwan Dollars (“TWD” or "TN"), the currency of the ROC. Transactions at the Company which are denominated in currencies other than TWD are translated into TWD at the exchange rate prevailing at the dates of the transactions. Exchange gains and losses resulting from transactions denominated in a currency other than that TWD are included in the statements of operation as exchange gains or loss. For financial reporting purpose, TWD has been translated into USD as the reporting currency in accordance with FASB ASC 830, “Foreign Currency Matters”. The financial information is first prepared in TWD and then is translated into USD at period-end exchange rates as to assets and liabilities and average exchange rates as to revenue and expenses. Capital accounts are translated at their historical exchange rates when the capital transactions occurred. The effects of foreign currency translation adjustments are included as a component of accumulated other comprehensive income in shareholders’ equity.

The exchange rates used for foreign currency translation were as follows (USD$1 = TWD):

September 30, 2014TWD: USD exchange rate

30.4

At September 30, 2014, the cumulative translation adjustments of $129,464, was classified as items of accumulated other comprehensive income in the owners’ equity section of the balance sheet.

Related parties

A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.

kj.

Recently issued accounting pronouncements

Accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s financial statements upon adoption.

Intangible Assets

Intangible assets are carried at cost. Amortization is calculated on a straight-line basis over the estimated useful life of the assets or a statutory period subscripted by the local law, without residual value. The percentages or amortizable life applied are:

Patents

20 years

Impairment of Long-life Assets

Long-lived assets and certain identifiable intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of

the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

Income Taxes

The Company accounts for income taxes in accordance with FASB ASC Topic 740 which requires that deferred tax assets and liabilities be recognized for future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases. In Addition, FASB ASC 740 requires recognition of future tax benefits, such as carry forwards, to the extent that realization of such benefits is more likely than not and that a valuation allowance be provided when it is more likely than not that some portion of the deferred tax asset will not be realized.

The Company accounts for income taxes in interim periods in accordance with FASB ASC 740-270, "Interim Reporting". The Company has determined an estimated annual effect tax rate. The rate will be revised, if necessary, as of the end of each successive interim period during the Company’s fiscal year to its best current estimate. The estimated annual effective tax rate is applied to the year-to-date ordinary income (or loss) at the end of the interim period.

Value-added Tax ("VAT")

Sales revenue represents the invoiced value of goods, net of a value-added tax (VAT). All of the Company’s products that are sold in ROC are subject to a value-added tax at a rate of 5% of the gross sales price or at a rate approved by the ROC local government. This VAT may be offset by VAT paid on purchase of raw materials included in the cost of producing the finished goods. The Company presents VAT on a net basis.

~~CONCENTRATION~~DUE OFTO ~~CREDIT~~RELATED ~~RISK~~PARTIES

~~Financial~~Due ~~instruments~~to ~~which~~related ~~potentially~~parties ~~expose~~represent temporally short-term loans from officers, directors, and majority shareholders, to finance the Company’s operation due to ~~concentrations~~lack of ~~credit~~cash ~~risk,~~resources. ~~consists~~There ofare ~~cash,~~no ~~accounts~~written ~~receivable~~loan agreements for these loans. These loans are unsecured, ~~prepaid~~non-interest ~~expenses~~bearing and ~~sundry~~have no fixed terms of repayment, ~~accounts~~therefore, deemed payable ~~and~~on ~~short-term~~demand. ~~loans~~Cash flows from due to related parties are classified as offrom ~~September~~financing 30activities. We borrowed $16,653 ~~2013.~~from ~~The~~a ~~Company~~related ~~performs~~part ~~ongoing~~in ~~evaluations~~the ofyear ~~its~~ended ~~cash~~December ~~position~~31, to2013, ~~minimize~~and ~~losses~~subsequently paid back this loan in February 2014.

~~A portion of the Company’s cash at September 30, 2013 is maintained at various financial institutions in the PRC which do not provide insurance for amounts on deposit~~4. ~~The Company has not experienced any losses in such accounts and believes it is not exposed to significant credit risk in this area.~~

ADVANCE FROM INVESTORS

Based on the ROC company laws, all capital contribution must be subject to the local government's approval. In order to finance the company's operation, the Board of Directors approved to accept capital contribution from investor. Based on the discretion of the Board of Directors, the Company will submit the capital contribution to the local government for approval. Before the capital contribution is approved by the local government, the investors can withdraw their investment fund as they wish. The investment fund bears no interest.

On July 10, 2013, the Board of Directors authorized Mr. Wu, Kevin (Guoquan), CEO of the Company, to seek capital funding in the over sea capital markets, such as the US capital market. The Company intends to merger with a US company, which will issue common stocks to acquire the Company via share exchange with the Company’s shareholders and investors.

On August 5, 2013, Kevin Wu, representing the Company and Shareholders of the Company (hereinafter referred to as “The Sellers") entered into a Letter of Intent with Analytical Bio-Energy Corp. (a Delaware Corporation) with its office located at 1896 Stoneybrook Court, Mississauga, Ontario, Canada L5L 3W2 (formally Uniwell Electronic Corporation) (hereinafter referred to as “The Buyer"). Pursuant to the Letter of Intent, the Buyer will transfer common stocks to the Sellers to acquire 100% of the Company. The transaction was subsequently closed on February 28, 2014.

The Buyer transferred 8,000,000 share of restricted common shares to the Sellers to acquire 100% of the Company. Originally the transaction called for 6,000,000 shares of restricted common stock. It was amended to 8,000,000 shares and the adjustment will be reflected in the 2014 financial statements of the consolidated entities. These common shares were issued in February 2014. These shares were then assigned to the Company’s shareholders, investors, and Management. The Company is working on the application of change of shareholders with the local government as of the date of release of these financial statements.

INCOME TAX

Under the rules of the Income Tax Law of the ROC, a company with its tax return certified by a Certified Public Accountant can carry forward its net loss as tax credits for the next 10 years. As of September 30, 2014, the Company's wholly owned subsidiary had accumulated losses eligible for refund of approximately $279,000.

FORWARD-LOOKING STATEMENTS

This document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objections of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements or belief; and any statements of assumptions underlying any of the foregoing.

Forward Looking Statements may include the words “may,” “could,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” or other similar words. These forward-looking statements present our estimates and assumptions only as of the date of this report. Except for our ongoing securities laws, we do not intend, and undertake no obligation, to update any forward-looking statement.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any or our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and inherent risks and uncertainties. The factors impacting these risks and uncertainties include, but are not limited to:

•·

increased competitive pressures from existing competitors and new entrants;

•·

our ability to raise adequate working capital;

•·

deterioration in general or regional economic conditions;

•·

adverse state or federal legislation or regulation that increases the costs of compliance, or adverse findings by a regulator with respect to existing operations;

•·

loss of customers or sales weakness;

•·

inability to achieve sales levels or other operating results;

•·

the unavailability of funds for capital expenditures; and

•·

operational inefficiencies.

For a detailed description of these and other factors that could cause actual results to differ materially from those expressed in any forward-looking statement, please see “Factors That May Affect Our Results of Operations” in this document.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Note Regarding Forward Looking Statements.

This quarterly report on Form 10-Q of Analytica Bio-Energy ~~Inc~~Corp. for the ~~period~~three months ended September 30, ~~2013~~2014, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements which, by definition, involve risks and uncertainties. In particular, statements under the Sections; Description of Business, Management's Discussion and Analysis of Financial Condition and Results of Operations contain forward-looking statements. Where, in any forward-looking statement, the Company expresses an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation or belief will result or be achieved or accomplished.

The following are factors that could cause actual results or events to differ materially from those anticipated, and include but are not limited to: general economic, financial and business conditions; changes in and compliance with governmental regulations; changes in tax laws; and the costs and effects of legal proceedings.


	(a)	an abrupt economic change resulting in an unexpected downturn in demand;
	(b)	governmental restrictions or excessive taxes on land;
	(c)	over-abundance of companies developing commercial properties to lease space or sell the developed building;
	(d)	economic resources to support the development of our projects;


	(e)	expansion plans, access to potential clients, and advances in technology; and
	(f)	lack of working capital that could hinder the land acquisition for development of our projects.

Financial information provided in this Form 10-Q, for periods subsequent to September 30, ~~2013~~2014, is preliminary and remains subject to audit. As such, this information is not final or complete, and remains subject to change, possibly materially.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following management’s discussion, analysis of financial condition should be read in conjunction with our financial statements and notes thereto contained elsewhere in this report.

~~PERIOD~~NINE MONTHS ENDED SEPTEMBER 30, ~~2013~~2014 COMPARED TO THE SAME PERIOD ENDED SEPTEMBER 30, ~~2012~~2013

Revenues

The Company generated $75,325 in sales ~~during~~for the nine ~~month~~months ~~period~~ ended September 30, ~~2013~~2014 ofas compared to $34,142 asfor ~~it commences its commercial activity in~~ the ~~most~~nine ~~recent~~months ~~quarter~~ ended September 30, 2013. ~~No sales were recorded in the comparable period ended September 30, 2012.~~

Cost of Revenues

The Company incurred ~~cost~~$42,368 in costs of sales during the nine ~~month~~months ~~period~~ ended September 30, ~~2013~~2014 ofas compared to $17,751. ~~No cost of sales were recorded~~ in the ~~comparable~~same nine month period ended September 30, ~~2012~~2013.

General and Administrative

The Company incurred administrative and general expenses of $~~149~~25,~~028~~954 ~~and~~for the nine months ended September 30, 2014 as compared to $15149,~~000~~028 in the ~~respective~~nine ~~periods~~months ended September 30, 2013 and ~~September~~mainly ~~30,~~consisted ~~2012, which consist entirely~~ of legal, listing and transfer agent fees required to keep the Company’s status as current for the nine months ended September 30, 2014.

Depreciation

There was depreciation for the period ended September 30, 2013, incurred of $5,440. No depreciation was recorded for the prior year period ended September 30, 2012.

Other Income/Expenses

In the period ended September 30, 2013, the Company earned minimal interest income or incurred minimal interest expenses.

Income Taxes

During the ~~period~~nine months ended September 30, ~~2013~~2014, we ~~incurred~~did nonot book any tax benefit nor ~~had~~has tothe ~~record~~company arecorded any provision for income taxes as the Company incurred a net loss and has significant loss carry forwards available to offset current and future net income results.

Net Income

The Company recorded a net loss for the period ended September 30, 2013 of $132,637 resulting from administrative, legal and listing fees required to maintain the Company’s filing status up to date. It is anticipated that this trend will continue into the next fiscal year.

Liquidity and Capital Resources

At September 30, ~~2013~~2014, the Company’s need for cash included satisfying $~~308~~110,~~647~~649 of current liabilities, which consisted entirely of accounts payable and accrued expenses. Current liabilities have increased ~~by $398,970 since July 31, 2013 mainly resulting~~ from the ~~acquisition.~~year ~~Accounts~~end ~~receivable~~to ~~increased by~~ $21805,~~188~~287.

The Company anticipates that its cash needs over the next 12 months will be met by primarily from three factors, increase in sales due to new contracts coming on line, shareholder loans and investment banking.

If the Company is unable to obtain additional funding sources of debt and equity capital, then the failure to obtain this funding could have a material adverse effect on the Company’s business and this may force the Company to reorganize, or to reduce the cost of all operations to a lower level of expenditure which may have the effect of reducing the Company’s expected revenues and net income for the fiscal year ~~2013~~2014.

We anticipate that our future liquidity requirements will arise from the need to fund our growth from our new operations, pay debt obligations and future capital expenditures. The primary sources of funding for such requirements are expected to be cash generated from new operations and raising additional funds from private sources and/or debt financing. However, we can provide no assurances that we will be able to generate sufficient cash flow from operations and/or obtain additional financing on terms satisfactory to us, if at all, to remain a going concern. Our continuation as a going concern is dependent upon our ability to generate sufficient cash flow to meet our obligations on a timely basis and ultimately to attain profitability.

Critical Accounting Policies and Estimates

The policies discussed below are considered by our management to be critical to an understanding of our financial statements because their application places the most significant demands on our management’s judgment, with financial reporting results relying on our estimation about the effect of matters that are inherently uncertain. Specific risks for these critical accounting policies are described below. For these policies, our management cautions that future events rarely develop as forecasted, and that best estimates may routinely require adjustment.

The SEC has issued cautionary advice to elicit more precise disclosure about accounting policies management believes are most critical in portraying our financial results and in requiring management’s most difficult subjective or complex judgments.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make judgments and estimates. On an ongoing basis, we evaluate our estimates, the most significant of which include establishing allowances for doubtful accounts and determining the recoverability of our long-lived tangible and intangible assets. The basis for our estimates are historical experience and various assumptions that are believed to be reasonable under the circumstances, given the available information at the time of the estimate, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily available from other sources. Actual results may differ from the amounts estimated and recorded in our financial statements.

We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our financial statements:

Basis of Presentation. The Company prepares its financial statements in conformity with generally accepted accounting principles in the United States of America. These principles require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the ~~reporting period. Management believes that these estimates are reasonable and have been discussed with the Board of Directors; however, actual results could differ from those estimates.~~

reporting period. Management believes that these estimates are reasonable and have been discussed with the Board of Directors; however, actual results could differ from those estimates.

Fair Value Instruments. The Company’s balance sheets include the following financial instruments: cash, accounts receivable, prepaid expenses and sundry, accounts payable and short-term loans. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization.

Income Taxes.

The Company accounts for income taxes under FASB Codification Topic 740 which requires use of the liability method. Topic 740 provides that deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purpose, referred to as temporary differences. Deferred tax assets and liabilities at the end of each period are determined using the currently enacted tax rates applied to taxable income in the periods in which the deferred tax assets and liabilities are expected to be settled or realized. A valuation allowance may be applied against the net deferred tax due to the uncertainty of its ultimate realization.

Off-Balance Sheet Arrangements

We have made no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Reclassification of Discontinued Operations

In accordance with the rules regarding the presentation of discontinued operations the assets, liabilities and activity of the business have been reclassified as a discontinued operation for all periods presented.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are a Smaller Reporting Company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Item 4. Controls and Procedures.

(a) Management’s Conclusions Regarding Effectiveness of Disclosure Controls and Procedures.

The management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting. The Company’s internal control over financial reporting is a process designed under the supervision of the Company’s Chief Executive Officer and Chief Financial Officer to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the Company’s financial statements for external purposes in accordance with U.S. generally accepted accounting principles.

With respect to the period ending September 30, ~~2013,~~2014 under the supervision and with the participation of our management, we conducted an evaluation of the effectiveness of the design and operations of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934.

Based upon our evaluation regarding the ~~period~~nine ~~ending~~months ended September 30, ~~2013~~2014, the Company’s management, including its Chief Executive Officer and Chief Financial Officer, has concluded that its disclosure controls and procedures were not effective due to the Company’s limited internal resources and lack of ability to have multiple levels of transaction review. Through the use of external consultants and the review process, management believes that the financial statements and other information presented herewith are materially correct.

The Company’s disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives. However, the Company’s management, including its Chief Executive Officer and Chief Financial Officer, does not expect that its disclosure controls and procedures will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefit of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

(b) Changes in Internal Controls.

There have been no changes in the Company’s internal control over financial reporting during the period ended September 30, ~~2013~~2014 that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial report

PART II – OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

We believe there are no changes that constitute material changes from the risk factors previously disclosed in the Company’s 2013 Annual Report filed on Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

During the period ending September 30, ~~2013~~2014, the Company did not issue any unregistered shares of its common stock.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mining Safety Disclosures.

None.

Item 5. Other Information.

None.

Item 6. Exhibits.

Exhibits


Exhibit number		Exhibit description

31.1		Certification pursuant to Section 302 of the Sarbanes-Oxley Act

32.1		Certification pursuant to Section 906 of the Sarbanes-Oxley Act

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

UNIWELL ELECTRONIC CORPORATION.

By:/s/ Luiz Brasil

Luiz Brasil, President,

President

Chief Executive Officer

Chief Financial Officer

Date: ~~November~~October 420, ~~2013~~2014

Filing Compare · ANALYTICA BIO-ENERGY CORP